Influence of CAR T-cell therapy associated complications
Since the introduction of chimeric antigen receptor (CAR) T-cell therapy, it has elicited an immense response in both targeted and residual cancers. Its clinical efficacy is often accompanied by a group of side effects that may become serious because of factors such as tumor burden, the extent of ly...
Saved in:
| Main Authors: | Mohammad Mussab Umair, Xun Lai, YuanBo Xue, Hong Yao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1494986/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling the influence of CAR-negative T-cells: enhancing efficacy and ensuring safety in CAR-T therapies
by: Belén Sierro-Martínez, et al.
Published: (2025-08-01) -
CAR T-cells meet autoimmune neurological diseases: a new dawn for therapy
by: Nikolaos A. Chinas, et al.
Published: (2025-07-01) -
Utilizing plasma exchange for severe cytokine release syndrome after CAR-T cell therapy: clinical experience and literature insights
by: Jiasi Zhang, et al.
Published: (2025-06-01) -
Building safety into CAR-T therapy
by: Daniel T. Peters, et al.
Published: (2023-12-01) -
A bibliometric and knowledge-map study of CAR-T cell-related cytokine release syndrome (CRS) from 2012 to 2023
by: Huimin Li, et al.
Published: (2023-12-01)